Toronto, ON --Almost $2 million is being invested by the Bill & Melinda Gates Foundation to help fight major parasitic diseases of the developing world.
The SGC-CHDI open access patent-free partnership for Huntington’s disease research has been selected as a featured Innovator to present on November 17th at the 6th annual Partnering for Cures meeting in New York City, NY. The conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D.
2014 is the International Year of Crystallography and to celebrate this event NDM has produced a series of short films.
‘Revolutionary Biology’: Revolutionary Biology shows how the field of structural biology has developed over the past 100 years, Oxford’s involvement in that development, and where we go from here.
SGC Toronto will hold a free workshop ‘EZH2 Inhibitors: Target Validation through Chemical Biology’, on February 9th, 2015 at the Princess Margaret Cancer Centre in Toronto, ON.
The goal of this event is to share practical knowledge gained using EZH2 inhibitors in various cellular and in vivo systems. In the spirit of sharing information, this workshop will be highly interactive.
The workshop will feature presentations from scientists in academia and industry. Participants are encouraged to submit posters from which 3-4 will be chosen for short oral presentations.
"Making pharmaceutical research more open could shave years off the time it takes to bring a new drug to market".
SGC's commitment to accelerating drug discovery is profiled by John Lorinc in the University of Toronto Magazine.